ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,122,652 | +1.4% | 396,440 | -3.4% | 0.07% | +4.7% |
Q2 2023 | $36,626,714 | -28.2% | 410,384 | -13.8% | 0.06% | -32.6% |
Q1 2023 | $51,038,950 | -4.4% | 476,021 | +8.9% | 0.10% | -20.2% |
Q4 2022 | $53,401,449 | +9.2% | 437,251 | -7.7% | 0.12% | +9.2% |
Q3 2022 | $48,895,000 | +16.4% | 473,519 | +4.8% | 0.11% | +19.8% |
Q2 2022 | $42,001,000 | -19.5% | 451,801 | +1.6% | 0.09% | -13.3% |
Q1 2022 | $52,170,000 | -8.3% | 444,559 | +5.2% | 0.10% | -1.9% |
Q4 2021 | $56,865,000 | -8.3% | 422,691 | +8.6% | 0.11% | -17.7% |
Q3 2021 | $62,039,000 | +58.1% | 389,223 | +30.5% | 0.13% | +49.4% |
Q2 2021 | $39,247,000 | +16.0% | 298,321 | +13.7% | 0.09% | +2.4% |
Q1 2021 | $33,830,000 | -16.6% | 262,392 | +7.9% | 0.08% | -19.0% |
Q4 2020 | $40,551,000 | +11.9% | 243,102 | +3.5% | 0.10% | 0.0% |
Q3 2020 | $36,229,000 | +62.6% | 234,774 | +55.8% | 0.10% | +52.2% |
Q2 2020 | $22,281,000 | +129.6% | 150,652 | +74.8% | 0.07% | +91.7% |
Q1 2020 | $9,705,000 | +5.8% | 86,186 | +30.8% | 0.04% | +33.3% |
Q4 2019 | $9,169,000 | +46.4% | 65,908 | +1.4% | 0.03% | +68.8% |
Q3 2019 | $6,262,000 | +23.4% | 65,009 | +47.5% | 0.02% | -5.9% |
Q2 2019 | $5,075,000 | +71.8% | 44,071 | +75.6% | 0.02% | +70.0% |
Q1 2019 | $2,954,000 | – | 25,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |